Abstract:A major challenge in osteosarcoma (OS) is the selection of the most effective chemotherapeutic agents for individual patients, while the administration of ineffective chemotherapy increases mortality and decreases quality of life in patients. This emphasizes the need to evaluate every patient's probability of responding to each chemotherapeutic agent. We developed a profiling strategy for serum exosomal microRNAs and mRNAs in OS patients with differential chemotherapeutic responses. Twelve miRNAs were up regulated and 18 miRNAs were under regulated significantly in OS patient with poor chemotherapeutic response when compared with those in good chemotherapeutic response (p<0.05). In addition, miR-124, miR133a, miR-199a-3p, and miR-385 were validated and significantly reduced in poorly responded patients with an independent OS cohort. While miR-135b, miR-148a, miR-27a, and miR-9 were significantly over expressed in serum exosomes. Bioinformatic analysis by DIANA-mirPath demonstrated that Proteoglycans in cancer, Hippo signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, PI3K-Akt signaling pathway, Ras signaling pathway, Ubiquitin mediated proteolysis, Choline metabolism in cancer were the most prominent pathways enriched in quantiles with the miRNA patterns related to poor chemotherapeutic response. Messenger RNAs(mRNAs) includingAnnexin2, Smad2, Methylthioadenosine phosphorylase (MTAP), Cdc42-interacting protein 4 (CIP4), Pigment Epithelium-Derived Factor (PEDF), WW domain-containing oxidoreductase (WWOX), Cell division cycle 5-like (Cdc5L), P27 were differentially expressed in exosomes in OS patients with different chemotherapeutic response. These data demonstrated that exosomal RNA molecules are reliable biomarkers in classifying osteosarcoma with different chemotherapy sensitivity.

Insights into Therapeutic Potential

Exosomes in Osteosarcoma Research and Preclinical Practice.

Exosomes as Efficient Nanocarriers in Osteosarcoma: Biological Functions and Potential Clinical Applications

The Potential Roles Of Exosomal Noncoding Rnas In Osteosarcoma

Exosomes and osteosarcoma drug resistance

The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy

Exosomes Containing Differential Expression of Microrna and Mrna in Osteosarcoma That Can Predict Response to Chemotherapy.

Exosomes in Bone Cancer: Unveiling their Vital Role in Diagnosis, Prognosis, and Therapeutic Advancements

Research progress about the role of exosomes in the pathogenesis of osteosarcoma

Exosomes: Emerging biomarkers and targets for ovarian cancer

Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications

Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle

Exosome's role in ovarian disease pathogenesis and therapy; Focus on ovarian cancer and failure

Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application

Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma

Extracellular vesicles as a new frontier of diagnostic biomarkers in osteosarcoma diseases: a bibliometric and visualized study

Exosome-based Tumor Therapy: Opportunities and Challenges.

Potential Mechanisms and Indication of Candidate Therapeutic Targets

Exosomes and Cell Communication: From Tumour-Derived Exosomes and Their Role in Tumour Progression to the Use of Exosomal Cargo for Cancer Treatment

Engineering Exosomes for Cancer Therapy

Unlocking the potential of exosomes in cancer research: A paradigm shift in diagnosis, treatment, and prevention